| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| AMICUS THERAPEUTICS, INC. | Director | Common Stock | 52.1K | $521K | $10.00 | Jun 6, 2024 | Direct |
| NEOGENOMICS INC | Director | Common Stock | 31.8K | $500K | $15.74 | Aug 10, 2024 | Direct |
| DMC Global Inc. | Director | Common Stock | 25.6K | $448K | $17.52 | May 15, 2024 | Direct |
| NEOGENOMICS INC | Director | Restricted Stock Unit | 12.3K | $193K | $15.74 | Jun 1, 2024 | Direct |
| Aprea Therapeutics, Inc. | Director | Common Stock | 4.61K | $17K | $3.68 | Jun 30, 2021 | Direct |
| NEOGENOMICS INC | Director | Restricted Stock Unit | 0 | $0 | $15.74 | Aug 10, 2024 | Direct |
| Prime Medicine, Inc. | Director | Stock Option (right to buy) | 45K | Jun 12, 2024 | Direct | ||
| AMICUS THERAPEUTICS, INC. | Director | Stock Options (right to buy) | 42.5K | Jun 6, 2024 | Direct | ||
| Aprea Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 22.8K | Jun 30, 2021 | Direct | ||
| HOOKIPA Pharma Inc. | Director | Stock Option (Right to Buy) | 20K | Jun 30, 2022 | Direct | ||
| NEOGENOMICS INC | Director | Stock Option (Right to Buy) | 8.67K | Aug 10, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| NEO | NEOGENOMICS INC | Aug 10, 2024 | 2 | $0 | 4 | Aug 13, 2024 | Director |
| PRME | Prime Medicine, Inc. | Jun 12, 2024 | 1 | $0 | 4 | Jun 14, 2024 | Director |
| FOLD | AMICUS THERAPEUTICS, INC. | Jun 6, 2024 | 2 | $0 | 4 | Jun 7, 2024 | Director |
| NEO | NEOGENOMICS INC | Jun 1, 2024 | 2 | $0 | 4 | Jun 4, 2024 | Director |
| BOOM | DMC Global Inc. | May 15, 2024 | 1 | $0 | 4 | May 15, 2024 | Director |
| NEO | NEOGENOMICS INC | Aug 10, 2023 | 2 | $0 | 4 | Aug 14, 2023 | Director |
| PRME | Prime Medicine, Inc. | Jun 14, 2023 | 1 | $0 | 4 | Jun 16, 2023 | Director |
| FOLD | AMICUS THERAPEUTICS, INC. | Jun 8, 2023 | 2 | $0 | 4 | Jun 12, 2023 | Director |
| BOOM | DMC Global Inc. | May 10, 2023 | 1 | $0 | 4 | May 10, 2023 | Director |
| PRME | Prime Medicine, Inc. | Oct 19, 2022 | 1 | $0 | 4 | Oct 21, 2022 | Director |
| PRME | Prime Medicine, Inc. | Oct 19, 2022 | 0 | $0 | 3 | Oct 19, 2022 | Director |
| HOOK | HOOKIPA Pharma Inc. | Jun 30, 2022 | 1 | $0 | 4 | Jul 1, 2022 | Director |
| NEO | NEOGENOMICS INC | Jun 10, 2022 | 2 | $0 | 4 | Jun 14, 2022 | Director |
| FOLD | AMICUS THERAPEUTICS, INC. | Jun 9, 2022 | 2 | $0 | 4 | Jun 10, 2022 | Director |
| BOOM | DMC Global Inc. | May 11, 2022 | 1 | $0 | 4 | May 12, 2022 | Director |
| APRE | Aprea Therapeutics, Inc. | Jun 30, 2021 | 2 | $0 | 4 | Jul 1, 2021 | Director |
| FOLD | AMICUS THERAPEUTICS, INC. | Jun 10, 2021 | 2 | $0 | 4 | Jun 14, 2021 | Director |
| NEO | NEOGENOMICS INC | Jun 2, 2021 | 2 | $0 | 4 | Jun 4, 2021 | Director |
| HOOK | HOOKIPA Pharma Inc. | Jun 1, 2021 | 1 | $0 | 4 | Jun 4, 2021 | Director |
| BOOM | DMC Global Inc. | May 12, 2021 | 1 | $0 | 4 | May 14, 2021 | Director |